Literature DB >> 2206057

Diagnosis and management of prenatally detected myelomeningocele: a preliminary report.

W A Hogge1, J S Dungan, M P Brooks, S A Dilks, P L Abbitt, S Thiagarajah, J E Ferguson.   

Abstract

Our experience with 23 cases of fetal myelomeningocele provides preliminary information on the outcome of these infants diagnosed in utero and managed by a multidisciplinary team. The mean age of diagnosis was 23.7 weeks (range, 16 to 34 weeks). Mean gestational age at delivery was 36.9 weeks in the 14 patients who elected to continue their pregnancies. None of the 11 infants with lumbosacral or sacral lesions developed significant ventriculomegaly before term. Of the three patients diagnosed with thoracolumbar lesions, two had progression of ventriculomegaly necessitating early delivery at 32 to 34 weeks of gestation. These preliminary findings suggest that a coordinated prenatal and neonatal approach appears to result in a favorable prognosis for infants with myelomeningocele, but that neonatal complications are common, requiring careful monitoring and aggressive management.

Entities:  

Mesh:

Year:  1990        PMID: 2206057     DOI: 10.1016/0002-9378(90)91127-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Assessment of neurosurgical outcome in children prenatally diagnosed with myelomeningocele and development of a protocol for fetal surgery to prevent hydrocephalus.

Authors:  Helder Zambelli; Edmur Carelli; Donizeti Honorato; Sérgio Marba; Giselle Coelho; Aline Carnevalle; Alexandre Iscaife; Elton da Silva; Ricardo Barini; Lourenço Sbragia
Journal:  Childs Nerv Syst       Date:  2007-01-17       Impact factor: 1.475

2.  Prenatal diagnosis and management of fetal hydrocephaly and lissencephaly.

Authors:  W Holzgreve; R Feil; F Louwen; P Miny
Journal:  Childs Nerv Syst       Date:  1993-11       Impact factor: 1.475

3.  Fetal surgery for myelomeningocele.

Authors:  Leslie N Sutton; N Scott Adzick; Mark P Johnson
Journal:  Childs Nerv Syst       Date:  2003-07-15       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.